首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1735437

全球微生物組定序市場

Global Microbiome Sequencing Market

出版日期: 2025年05月21日 | 出版商:

BCC Research | 英文 124 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球微生物定序市場規模預計將從2024年的15億美元擴大到2029年底的37億美元，2024年至2029年的年複合成長率為 19.3%。

預計北美市場規模將從2024年的5.398億美元擴大到2029年底的12億美元，同期的年複合成長率為 17.6%。

預計歐洲市場規模將從2024年的4.445億美元擴大到2029年底的11億美元，同期的年複合成長率為20.0%。

本報告調查了全球微生物定序市場，並提供了市場概況的摘要、市場影響因素和市場機會的分析、法律制度、新興技術和技術發展的趨勢、市場規模的趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業的概況。

市場趨勢
細分市場
微生物組定序：全球市場
定序技術市場分析
高通量定序
桑格定序
第三代定序
組件市場分析
試劑和套件
裝置
市場分析：依實驗室類型
濕實驗室
乾實驗室
市場分析：依應用
疾病診斷研究
個人化醫療
藥物研發
基因檢測
其他
依最終用戶分類的市場分析
製藥和生物技術
學術中心和研究機構
其他
地理分佈
市場區隔：依地區
北美洲
歐洲
亞太地區
中東和非洲
南美洲

第7章競爭態勢

主要供應商和製造商
微生物組定序序產業公司排名
戰略分析

第8章環境、社會與管治（ESG）視角

微生物組定序市場的永續性
ESG風險與評級等：解讀資料
BCC的結語

第9章附錄

調查方法
來源
簡稱
公司簡介
BASECLEAR BV
CD GENOMICS
CHARLES RIVER LABORATORIES
COSMOSID
CROWN BIOSCIENCE
DANAHER CORP.
EUROFINS SCIENTIFIC
ILLUMINA INC.
MERIEUX NUTRISCIENCES
MICROBIOME INSIGHTS
NOVOGENE CO. LTD.
OXFORD NANOPORE TECHNOLOGIES PLC
PACBIO
QIAGEN
THERMO FISHER SCIENTIFIC INC.
Emerging Startups
Pendulum
Microba
Biomesense

簡介目錄圖表

Product Code: BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

The North American microbiome sequencing market is expected to grow from $539.8 million in 2024 and is projected to reach $1.2 billion by the end of 2029, at a CAGR of 17.6% during the forecast period of 2024 to 2029.

The European microbiome sequencing market is expected to grow from $444.5 million in 2024 and is projected to reach $1.1 billion by the end of 2029, at a CAGR of 20.0% during the forecast period of 2024 to 2029.

Report Scope

The report analyzes the microbiome sequencing market by component, sequencing technology, laboratory type, application and end user, offering insights into key trends and growth drivers. The study concludes with an analysis of leading companies and their offerings. The base year for the study is 2023, the estimated year is 2024 with projections through 2029, including compound annual growth rate (CAGR) for the forecast period.

This report analyzes the macroeconomic factors affecting the market. Market drivers, restraints and opportunities are identified. The report covers the regulatory landscape, recent technologies and patents in the market, as well as innovations in products and performance. The report also covers the competitive landscape, ESG factors and profiles of leading companies.

Regional analysis covers North America (U.S., Canada and Mexico), Europe (U.K., Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific), Middle East and Africa (MEA) and South America (Brazil, Argentina and Rest of South America).

Report Includes

50 data tables and 51 additional tables
Analyses of the global market trends for microbiome sequencing technologies, with revenue data from 2021-2024, and projected CAGRs through 2029
Estimates of the size and revenue prospects for the global market, along with a market share analysis by sequencing technology, component, laboratory type, application, end user and region
Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
A look at the emerging trends and opportunities in microbiome-based therapeutics, clinical trials
Evaluation of recent patent activity and key granted and published patents
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of leading companies including Illumina Inc., Qiagen, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Plc., and PacBio.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Outlook
Macroeconomic Analysis
Impact of U.S.-China Trade War

Chapter 3 Market Dynamics

Market Drivers
Decreasing Cost per Genome
Government Initiatives and Funding
Advances in Sequencing Technology
Market Restraints
Data Complexity and Bioinformatics Challenges
Lack of Standardized Protocols and Reference Databases
Lack of Grant Funding
Market Opportunities
Personalized Medicine and Diagnostics
Drug Discovery and Development
Agriculture and the Food Industry

Chapter 4 Regulatory Landscape

Overview

Chapter 5 Emerging Technologies and Patent Analysis

Emerging Technologies
Nanopore Sequencing
SMRT Sequencing
FACS with Microfluidics
Metatranscriptome Sequencing
Patent Analysis
Regional Patterns

Chapter 6 Market Segment Analysis

Market Trends
Segmentation Breakdown
Microbiome Sequencing: Global Markets
Market Analysis by Sequencing Technology
High-throughput Sequencing
Sanger Sequencing
Third-Generation Sequencing
Market Analysis by Component
Reagents and Kits
Instruments
Market Analysis by Laboratory Type
Wet Labs
Dry Labs
Market Analysis by Application
Disease Diagnosis Research
Personalized Medicine
Drug Discovery
Genetic Screening
Other Applications
Market Analysis by End User
Pharmaceutical and Biotechnology
Academic Centers and Research Institutes
Other End Users
Geographic Breakdown
Market Breakdown by Region
North America
Europe
Asia-Pacific
MEA
South America

Chapter 7 Competitive Landscape

Key Suppliers and Manufacturers
Ranking of Companies in the Microbiome Sequencing Industry
Strategic Analysis

Chapter 8 Environmental, Social, and Governance (ESG) Perspective

Sustainability in the Microbiome Sequencing Market
ESG Risks and Ratings: Understanding the Data
BCC Research Viewpoint

Chapter 9 Appendix

Research Methodology
Sources
Abbreviations
Company Profiles
BASECLEAR BV
CD GENOMICS
CHARLES RIVER LABORATORIES
COSMOSID
CROWN BIOSCIENCE
DANAHER CORP.
EUROFINS SCIENTIFIC
ILLUMINA INC.
MERIEUX NUTRISCIENCES
MICROBIOME INSIGHTS
NOVOGENE CO. LTD.
OXFORD NANOPORE TECHNOLOGIES PLC
PACBIO
QIAGEN
THERMO FISHER SCIENTIFIC INC.
Emerging Startups
Pendulum
Microba
Biomesense

簡介目錄圖表

List of Tables

Summary Table : Global Market for Microbiome Sequencing, by Region, Through 2029
Table 1 : Cost Per Genome, 2019-2022
Table 2 : FDA-Approved Personalized Medicines, 2015-2022
Table 3 : Regulatory Scenario for Microbiome Sequencing, by Country
Table 4 : Global Market for Microbiome Sequencing, Through 2029
Table 5 : Global Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 6 : NGS Technologies
Table 7 : Experimental HTS Technology
Table 8 : Illumina's Two-Channel SBS Instruments
Table 9 : Comparison of Sanger Sequencing and Targeted NGS
Table 10 : Global Market for Microbiome Sequencing, by Component, Through 2029
Table 11 : Pricing of Microbiome Products, by Company
Table 12 : Global Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 13 : Global Market for Microbiome Sequencing, by Application, Through 2029
Table 14 : Global Market for Microbiome Sequencing Market, by End User, Through 2029
Table 15 : Partnerships between Biotech and Pharma Companies for Microbiome Projects
Table 16 : Academic Centers and Research Institutes Engaged in Microbiome Research
Table 17 : Global Market for Microbiome Sequencing, by Region, Through 2029
Table 18 : North American Market for Microbiome Sequencing, by Country, Through 2029
Table 19 : North American Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 20 : North American Market for Microbiome Sequencing, by Component, Through 2029
Table 21 : North American Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 22 : North American Market for Microbiome Sequencing, by Application, Through 2029
Table 23 : North American Market for Microbiome Sequencing, by End User, Through 2029
Table 24 : European Market for Microbiome Sequencing, by Country, Through 2029
Table 25 : European Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 26 : European Market for Microbiome Sequencing, by Component, Through 2029
Table 27 : European Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 28 : European Market for Microbiome Sequencing, by Application, Through 2029
Table 29 : European Market for Microbiome Sequencing, by End User, Through 2029
Table 30 : Asia-Pacific Market for Microbiome Sequencing, by Country, Through 2029
Table 31 : Asia-Pacific Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 32 : Asia-Pacific Market for Microbiome Sequencing, by Component, Through 2029
Table 33 : Asia-Pacific Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 34 : Asia-Pacific Market for Microbiome Sequencing, by Application, Through 2029
Table 35 : Asia-Pacific Market for Microbiome Sequencing, by End User, Through 2029
Table 36 : MEA Market for Microbiome Sequencing, by Region, Through 2029
Table 37 : MEA Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 38 : MEA Market for Microbiome Sequencing, by Component, Through 2029
Table 39 : MEA Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 40 : MEA Market for Microbiome Sequencing, by Application, Through 2029
Table 41 : MEA Market for Microbiome Sequencing, by End User, Through 2029
Table 42 : South American Market for Microbiome Sequencing, by Country, Through 2029
Table 43 : South American Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 44 : South American Market for Microbiome Sequencing, by Component, Through 2029
Table 45 : South American Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 46 : South American Market for Microbiome Sequencing, by Application, Through 2029
Table 47 : South American Market for Microbiome Sequencing, by End User, Through 2029
Table 48 : Ranking of Leading Companies in the Microbiome Sequencing Industry, 2023
Table 49 : Strategic Analysis in the Microbiome Sequencing Industry
Table 50 : ESG Rankings for Major Microbiome Sequencing Companies*
Table 51 : Information Sources for This Report
Table 52 : Abbreviations Used in the Report
Table 53 : BaseClear BV: Company Snapshot
Table 54 : BaseClear BV: Product Portfolio
Table 55 : CD Genomics: Company Snapshot
Table 56 : CD Genomics: Product Portfolio
Table 57 : Charles River Laboratories: Company Snapshot
Table 58 : Charles River Laboratories: Financial Performance, FY 2023 and 2024
Table 59 : Charles River Laboratories: Product Portfolio
Table 60 : Charles River Laboratories: News/Key Developments, 2023
Table 61 : CosmosID: Company Snapshot
Table 62 : CosmosID: Product Portfolio
Table 63 : CosmosID: News/Key Developments, 2022
Table 64 : Crown Bioscience: Company Snapshot
Table 65 : Crown Bioscience: Product Portfolio
Table 66 : Danaher Corp.: Company Snapshot
Table 67 : Danaher Corp.: Financial Performance, FY 2023 and 2024
Table 68 : Danaher Corp.: Product Portfolio
Table 69 : Danaher Corp.: News/Key Developments, 2024
Table 70 : Eurofins Scientific: Company Snapshot
Table 71 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 72 : Eurofins Scientific: Product Portfolio
Table 73 : Illumina Inc.: Company Snapshot
Table 74 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 75 : Illumina Inc.: Product Portfolio
Table 76 : Illumina Inc.: News/Key Developments, 2022-2025
Table 77 : Merieux NutriSciences: Company Snapshot
Table 78 : Merieux NutriSciences: Product Portfolio
Table 79 : Microbiome Insights: Company Snapshot
Table 80 : Microbiome Insights: Product Portfolio
Table 81 : Microbiome Insights: News/Key Developments, 2024
Table 82 : Novogene Co. Ltd.: Company Snapshot
Table 83 : Novogene Co. Ltd.: Financial Performance, FY 2023 and 2024
Table 84 : Novogene Co. Ltd.: Product Portfolio
Table 85 : Oxford Nanopore Technologies plc: Company Snapshot
Table 86 : Oxford Nanopore Technologies plc: Financial Performance, FY 2023 and 2024
Table 87 : Oxford Nanopore Technologies plc: Product Portfolio
Table 88 : Oxford Nanopore Technologies plc: News/Key Developments, 2024
Table 89 : PacBio: Company Snapshot
Table 90 : PacBio: Financial Performance, FY 2023 and 2024
Table 91 : PacBio: Product Portfolio
Table 92 : PacBio: News/Key Developments, 2023 and 2024
Table 93 : QIAGEN: Company Snapshot
Table 94 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 95 : QIAGEN: Product Portfolio
Table 96 : QIAGEN: News/Key Developments, 2024
Table 97 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 98 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 99 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 100 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023

List of Figures

Summary Figure : Global Market Shares of Microbiome Sequencing, by Region, 2023
Figure 1 : Market Dynamics
Figure 2 : Emerging Technologies in Microbiome Sequencing
Figure 3 : Global Market Shares for Microbiome Sequencing, by Sequencing Technology, 2023
Figure 4 : Global Market Shares for Microbiome Sequencing, by Sequencing Technology, 2023
Figure 5 : Global Market Shares for Microbiome Sequencing, by Component, 2023
Figure 6 : Global Market Shares for Microbiome Sequencing, by Laboratory Type, 2023
Figure 7 : Global Market Shares for Microbiome Sequencing, by Application, 2023
Figure 8 : Global Market Shares for Microbiome Sequencing, by End User, 2023
Figure 9 : Global Market Shares for Microbiome Sequencing, by Region, 2023
Figure 10 : North American Market Shares for Microbiome Sequencing, by Country, 2023
Figure 11 : European Market Shares for Microbiome Sequencing, by Country, 2023
Figure 12 : Asia-Pacific Market Shares for Microbiome Sequencing, by Country, 2023
Figure 13 : MEA Market Shares for Microbiome Sequencing, by Region, 2023
Figure 14 : South American Market Shares for Microbiome Sequencing, by Country, 2023
Figure 15 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2024
Figure 16 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2024
Figure 17 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 18 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 19 : Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023
Figure 20 : Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023
Figure 21 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 22 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 23 : Oxford Nanopore Technologies plc: Revenue Shares, by Business Unit, FY 2024
Figure 24 : Oxford Nanopore Technologies plc: Revenue Shares, by Country/Region, FY 2024
Figure 25 : PacBio: Revenue Shares, by Business Unit, FY 2024
Figure 26 : PacBio: Revenue Shares, by Country/Region, FY 2024
Figure 27 : QIAGEN: Revenue Shares, by Business Unit, 2023
Figure 28 : QIAGEN: Revenue Shares, by Country/Region, 2023
Figure 29 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, 2024
Figure 30 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, 2024